This secondary analysis of the 3-year results of the 24-Month Myopia Outcome Study of Atropine in Children (MOSAIC) randomized clinical trial investigates the efficacy and safety of different atropine eye drop regimens, 0.05% and 0.01%, in treating myopia progression in European eyes.
Visionary News & Insightful Strategy
Footer
A RETINA-SPECIFIC ORGANIZATION
It’s clearly an advantage to work with a consulting group that’s focused on your industry. The team at Retina Consultant has over 50 years of retina-specific experience in healthcare business, practice management, marketing & operations.
We’ve got our eyes on working with the best retina groups and vendors in the industry.
See the best; get in touch.
Recent
- FDA clears Epithelial Thickness Module for Anterion imaging platform
- Heidelberg Engineering announces FDA clearance for ANTERION Epithelial Thickness Module, Ectasia View
- Q&A: Expert offers tips on how to grow your brand, practice with social media
- Woman presents with bilateral floaters, foggy vision
- Variety of scleral fixation techniques can replace or rescue IOL
Leave a Reply